Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
24.15
-0.22 (-0.90%)
Jun 16, 2026, 4:00 PM EDT - Market closed

Pediatrix Medical Group Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Pediatrix Medical Group stock has a consensus rating of "Buy" and an average price target of $23.17. The average 1-year stock price forecast is 4.06% lower than the current stock price, while the lowest is $19 (-21.33%) and the highest is $27 (+11.80%).

Price Target: $23.17 (-4.06%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$19$23.17$23.5$27
Change-21.33%-4.06%-2.69%+11.80%
* Price targets were last updated on May 12, 2026.

Analyst Ratings

The average analyst rating for Pediatrix Medical Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingOct '25Nov '25Jan '26Feb '26Apr '26May '26
Strong Buy222222
Buy000000
Hold555555
Sell000000
Strong Sell000000
Total777777

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Hold
Maintains
$22$25
HoldMaintains$22$25+3.52%May 12, 2026
Mizuho Securities
Mizuho Securities
Hold
Maintains
$21$24
HoldMaintains$21$24-0.62%May 8, 2026
Truist Financial
Truist Financial
Hold
Maintains
$23
HoldMaintains$23-4.76%May 6, 2026
William Blair
William Blair
Buy
Reiterates
$22
BuyReiterates$22-8.90%May 5, 2026
Jefferies
Jefferies
Buy
Maintains
$24$27
BuyMaintains$24$27+11.80%Apr 20, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.94B
from 1.91B
Increased by 1.30%
Revenue Next Year
1.99B
from 1.94B
Increased by 2.53%
EPS This Year
2.28
from 2.04
Increased by 11.58%
EPS Next Year
2.36
from 2.28
Increased by 3.66%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.91B1.97B1.99B2.01B1.91B1.94B
Revenue Growth
10.22%3.18%1.15%0.92%-4.92%1.30%
Gross Profit
513.24M467.03M421.57M454.34M493.70M504.96M
Gross Margin
26.85%23.68%21.13%22.57%25.80%26.05%
Operating Income
217.74M200.00M157.85M183.68M231.09M250.31M
Net Income
130.96M66.34M-60.41M-99.07M165.39M163.26M
EPS
----2.042.28
EPS Growth
----35.10%11.58%
Forward PE
16.258.297.408.869.9210.61
Free Cash Flow
61.19M136.08M69.20M173.92M190.33M158.33M
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High1.9B
Avg1.9B
Low1.9B

Revenue Growth

Revenue Growth202620272028
High
1.6%
Avg
1.3%
Low
0.6%

EPS Forecast

EPS202620272028
High-
Avg2.28
Low-

EPS Growth

EPS Growth202620272028
High-
Avg
11.6%
Low-